These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28424575)

  • 21. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Heart; 2018 Mar; 104(6):525-532. PubMed ID: 28982721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Pascual-Figal DA; Ferrero-Gregori A; Gomez-Otero I; Vazquez R; Delgado-Jimenez J; Alvarez-Garcia J; Gimeno-Blanes JR; Worner-Diz F; Bardají A; Alonso-Pulpon L; Gonzalez-Juanatey JR; Cinca J;
    Int J Cardiol; 2017 Aug; 240():265-270. PubMed ID: 28318662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction.
    Ardelean CL; Pescariu S; Lighezan DF; Pleava R; Ursoniu S; Nadasan V; Mihaicuta S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31394863
    [No Abstract]   [Full Text] [Related]  

  • 28. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop.
    Mehra R; Tjurmina OA; Ajijola OA; Arora R; Bolser DC; Chapleau MW; Chen PS; Clancy CE; Delisle BP; Gold MR; Goldberger JJ; Goldstein DS; Habecker BA; Handoko ML; Harvey R; Hummel JP; Hund T; Meyer C; Redline S; Ripplinger CM; Simon MA; Somers VK; Stavrakis S; Taylor-Clark T; Undem BJ; Verrier RL; Zucker IH; Sopko G; Shivkumar K
    JACC Basic Transl Sci; 2022 Mar; 7(3):265-293. PubMed ID: 35411324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
    Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
    J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction.
    Tromp J; Khan MAF; Mentz RJ; O'Connor CM; Metra M; Dittrich HC; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JGF; Givertz MM; Bloomfield DM; Van Veldhuisen DJ; Hillege HL; Voors AA; van der Meer P
    JACC Heart Fail; 2017 Jul; 5(7):507-517. PubMed ID: 28624483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies.
    Unkovic P; Basuray A
    Curr Treat Options Cardiovasc Med; 2018 Apr; 20(4):35. PubMed ID: 29616374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry.
    Guisado-Espartero ME; Salamanca-Bautista P; Aramburu-Bodas Ó; Conde-Martel A; Arias-Jiménez JL; Llàcer-Iborra P; Dávila-Ramos MF; Cabanes-Hernández Y; Manzano L; Montero-Pérez-Barquero M;
    Int J Cardiol; 2018 Mar; 255():124-128. PubMed ID: 29305104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
    Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(10):2209-15. PubMed ID: 26227392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ
    JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF.
    Savarese G; Orsini N; Hage C; Vedin O; Cosentino F; Rosano GMC; Dahlström U; Lund LH
    JACC Heart Fail; 2018 Mar; 6(3):246-256. PubMed ID: 29428439
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.